This content is from: United States
Pfizer and AstraZeneca go separate ways…for now
After the failure of the Pfizer-AstraZeneca transaction at the end of May, the two companies have now announced new deals with other companies. But the two drugs companies could return to the proposed inversion deal later this year.
To access our market-driven intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an ITR subscriber? Log in here